Vestcor Inc Cuts Stake in Cigna Group $CI

Vestcor Inc reduced its stake in Cigna Group (NYSE:CIFree Report) by 21.5% during the third quarter, HoldingsChannel.com reports. The fund owned 11,968 shares of the health services provider’s stock after selling 3,280 shares during the quarter. Vestcor Inc’s holdings in Cigna Group were worth $3,450,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CI. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after purchasing an additional 4,738 shares during the last quarter. Maj Invest Holding A S boosted its position in Cigna Group by 2.4% in the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after buying an additional 10,042 shares during the period. Providence Capital Advisors LLC increased its position in shares of Cigna Group by 1,016.8% during the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after acquiring an additional 7,748 shares during the period. National Pension Service raised its stake in shares of Cigna Group by 3.2% during the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock valued at $197,091,000 after acquiring an additional 21,203 shares in the last quarter. Finally, SCS Capital Management LLC boosted its holdings in shares of Cigna Group by 39.1% in the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after purchasing an additional 8,609 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Shares of NYSE CI opened at $262.13 on Wednesday. The firm’s 50 day simple moving average is $280.29 and its 200-day simple moving average is $283.45. The stock has a market capitalization of $69.08 billion, a price-to-earnings ratio of 11.82, a PEG ratio of 0.93 and a beta of 0.27. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the previous year, the firm earned $6.64 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 28.13%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. Truist Financial lifted their price objective on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Robert W. Baird dropped their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Barclays reduced their price target on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Finally, Piper Sandler dropped their target price on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average target price of $330.42.

View Our Latest Research Report on CI

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.